Demographics | Strains cohorts | P Value | |
---|---|---|---|
PLA (n = 25) | VAP (n = 14) | ||
Age (y, mean ± SD) | 53.31 ± 17.54 | 67.86 ± 23.13 | < 0.001 |
Genders (male) | 16 (64%) | 8 (57.14%) | Â |
Genders (Female) | 9 (36%) | 6 (42.86%) | Â |
Comorbidity | |||
Renal insufficiency | 4 (16%) | 5 (35.71%) | Â |
Diabetes mellitus | 9 (36%) | 3 (22.22%) | < 0.001 |
Biliary tract disease | 7 (28%) | 0 | < 0.001 |
Cholelithiasis | 5 (20%) | 1 (7.14%) | Â |
Smoking history | 5 (20%) | 4 (28.57%) | Â |
Hypertension | 2 (8%) | 5 (35.71%) | Â |
Respiratory insufficiency | 1 (4%) | 11 (78.57%) | Â |
Septic pulmonary embolism | 2 (8%) | 5 (35.71%) | Â |
Co-infection | 0 | 6 (42.85%) | < 0.001 |
Hospital stays (day) | 17.21 ± 8.42 | 46.32 ± 24.25 | < 0.001 |
Deceased | 1 (4.34%) | 4 (23.53%) | < 0.001 |